The Utility of Mass Spectrometry in Defining Minimal Residual Disease in Treated Multiple Myeloma Patients

被引：0
|
作者：
Campbell, Lauren [1 ]
Lau, I-Jun [2 ]
Ramasamy, Karthik [3 ]
Sadler, Ross [1 ]
机构：
[1] Oxford Univ Hosp NHS Fdn Trust, Oxford, England
[2] Botnar Inst, Oxford, England
[3] Radcliffe Dept Med, Oxford, England
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-184
引用
收藏
页码：S144 / S145
页数：2
相关论文
共 50 条
  • [21] Using MALDI-TOF mass spectrometry for tracking of minimal residual disease in peripheral blood from patients with multiple myeloma.
    Eveillard, Marion
    Rustad, Even
    Roshal, Mikhail
    Zhang, Yanming
    Ciardiello, Amanda
    Korde, Neha
    Hultcrantz, Malin
    Hassoun, Hani
    Smith, Eric L.
    Lesokhin, Alexander M.
    Mailankody, Sham
    Landgren, Carl Ola
    Thoren, Katie
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [22] Monitoring Minimal Residual Disease in Patients with Multiple Myeloma by Targeted Tracking Serum M-Protein Using Mass Spectrometry (EasyM)
    Fan, Huishou
    Wang, Bing
    Shi, Lihui
    Pan, Ni
    Yan, Wenqiang
    Xu, Jingyu
    Gong, Lixin
    Li, Lingna
    Liu, Yuntong
    Du, Chenxing
    Cui, Jian
    Zhu, Guoqing
    Deng, Shuhui
    Sui, Weiwei
    Xu, Yan
    Yi, Shuhua
    Hao, Mu
    Zou, Dehui
    Chen, Xiequn
    Qiu, Lugui
    An, Gang
    CLINICAL CANCER RESEARCH, 2024, 30 (06) : 1131 - 1142
  • [23] Multiple myeloma, immunotherapy and minimal residual disease
    Kusenda, J.
    Kovarikova, A.
    NEOPLASMA, 2016, 63 (05) : 651 - 658
  • [24] Minimal residual disease monitoring in multiple myeloma
    Davies, FE
    Rawstron, RC
    Owen, RG
    Morgan, GJ
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (01) : 197 - 222
  • [25] Standardisation of minimal residual disease in multiple myeloma
    Innao, V.
    Allegra, A.
    Russo, S.
    Gerace, D.
    Vaddinelli, D.
    Alonci, A.
    Allegra, A. G.
    Musolino, C.
    EUROPEAN JOURNAL OF CANCER CARE, 2017, 26 (06)
  • [26] Editorial: Minimal residual disease (MRD) assessment in multiple myeloma patients
    Maiolino, Angelo
    Da Costa, Elaine Sobral
    Orfao, Alberto
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [27] Minimal Residual Disease Monitoring During Maintenance In Multiple Myeloma Patients
    Rocci, Alberto
    Gambella, Manuela
    Omede, Paola
    Drandi, Daniela
    Gay, Francesca
    Patriarca, Francesca
    Cavallo, Federica
    Petrucci, Maria Teresa
    Tommaso, Caravita
    Benevolo, Giulia
    Pescosta, Norbert
    Oliva, Stefania
    Offidani, Massimo
    Montefusco, Vittorio
    Liberati, Anna Marina
    Falcone, Antonietta Pia
    Ballanati, Stelvio
    Spadano, Tonino
    Guglielmelli, Tommasina
    Musto, Pellegrino
    Zarnbello, Renato
    Di Raimondo, Francesco
    Ladetto, Marco
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2013, 122 (21)
  • [28] Role of Imaging in the Evaluation of Minimal Residual Disease in Multiple Myeloma Patients
    Zamagni, Elena
    Tacchetti, Paola
    Barbato, Simona
    Cavo, Michele
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (11) : 1 - 9
  • [29] Minimal Residual Disease in Multiple Myeloma: Targeted Mass Spectrometry in Blood Vs Next Generation Sequencing in Bone Marrow
    Zajec, Marina
    Langerhorst, Pieter
    Noori, Somayya
    van Duijn, Martijn
    de Rijke, Yolanda
    Gloerich, Jolein
    van Gool, Alain
    Corre, Jill
    Dejoie, Thomas
    Caillon, Helene
    Jacobs, Joannes
    Luider, Theo
    Avet-Loiseau, Herve
    BLOOD, 2020, 136
  • [30] Mass Spectrometry-Based Method Targeting Ig Variable Regions for Assessment of Minimal Residual Disease in Multiple Myeloma
    Martins, Carlo O.
    Huet, Sarah
    Yi, San S.
    Ritorto, Maria S.
    Landgren, Ola
    Dogan, Ahmet
    Chapman, Jessica R.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (07): : 901 - 911
12345